Pheochromocytoma: Diagnosis and management update

Current Hypertension Reports

Volumn 6, Issue 6, 2004, Pages 477-484

  Manger, William M ^a   Eisenhofer, Graeme ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 131; 6 FLUORODOPAMINE; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUSPIRONE; CALCIUM CHANNEL BLOCKING AGENT; CATECHOLAMINE; CLONIDINE; CYCLOPHOSPHAMIDE; DACARBAZINE; FLUORINE 18; GLYCERYL TRINITRATE; IODINE 123; ISOPRENALINE; LABETALOL; LEVODOPA; METADRENALIN; METHYLDOPA; MONOAMINE OXIDASE INHIBITOR; NITROPRUSSIDE SODIUM; NORADRENALIN; PARACETAMOL; PHENOXYBENZAMINE; PHENTOLAMINE; PSEUDOEPHEDRINE; RESERPINE; TRANQUILIZER; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VINCRISTINE;

BLOOD LEVEL; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CATECHOLAMINE RELEASE; CIRCULATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ERROR; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; ELECTROCARDIOGRAPHY; FAMILIAL CANCER; FATALITY; HUMAN; HYPERTENSION; LABORATORY TEST; MALIGNANT NEOPLASTIC DISEASE; NEUROENDOCRINE TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHEOCHROMOCYTOMA; REVIEW; SENSITIVITY AND SPECIFICITY; SURGICAL TECHNIQUE; TREATMENT PLANNING; TUMOR LOCALIZATION; URINE LEVEL;

EID: 10044272881     PISSN: 15226417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11906-004-0044-2     Document Type: Review

References (31)

1. Sutton M, Sheps SG, Lie JL: Prevalence of clinically unsuspected pheochromocytoma: review of a 50-year autopsy series. Mayo Clin Proc 1981, 56:354-360.
2. McNeil AR, Blok BH, Koelmeyer TD, et al.: Pheochromocytomas discovered during coronal autopsies in Sydney, Melbourne and Auckland. Aust N Z J Med 2000, 30:648-652.
3. Manger WM, Gifford RW Jr: Clinical and Experimental Pheochromocytoma. Cambridge. MA: Blackwell Science; 1996.
4. Whalen RK, Althausen AF, Daniels GH: Extra-adrenal pheochromocytoma. J Urol 1992, 147:1-10.
5. Pacak K, Linehamn WM, Eisenhofer G, et al.: Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma. Ann Intern Med 2001, 135:315-329.
6. Neumann HP, Bausch B, McWhinney SR, et al.: Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med 2002, 346:1459-1466.
7. Neuman HPH, Denkel E, Brambs H, et al.: Pancreatic lesions in the Von Hippel-Lindau syndrome. Gastroenterology 1991, 101:465-471.
8. Bergland BE: Pheochromocytoma presenting as shock. Am J Emerg Med 1989, 7:44-48.
9. Newell KA, Prinz RA, Pickleman J, et al.: Pheochromocytoma multisystem crisis: a surgical emergency. Arch Surg 1988, 123:956-959.
10. Lenders JWM, Pacak K, Walther MM, et al.: Biochemical diagnosis of pheochromocytoma: Which test is best? JAMA 2002, 287:1427-1434.
11. Raber W, Raffesberg W, Bischof M, et al.: Diagnostic efficacy of unconjugated plasma metanephrines for detection of pheochromocytoma. Arch Intern Med 2000, 160:2957-2963.
12. Eisenhofer G, Goldstein DS, Walther MM: Biochemical diagnosis of pheochromocytoma: How to distinguish true from false-positive test results. J Clin Endocrinol Metab 2003, 88:2656-2666.
13. Manger WM, Gifford RW Jr: Pheochromocytoma. In Endocrine Mechanisms in Hypertension. Edited by Laragh JH, Brenner BM, Kaplan NM. New York, NY: Raven Press; 1989:19-59.
14. Jebara VA, Uva MS, Farge A, et al.: Cardiac pheochromocytomas. Ann Thorac Surg 1992, 53:356-361.
15. Fink IJ, Reinig JW, Dwyer AJ, et al.: MR imaging of pheochromocytomas. J Comput Assist Tomogr 1985, 9:454-458.
16. Baker EM, Spritzer C, Blinder R, et al.: Benign adrenal lesions mimicking malignancy on MR imaging: report of two cases Radiology 1987, 163:669-671.
17. Stowers SA, Gilmore F, Sterling M, et al.: Cardiac pheochromocytoma involving the left main coronary artery presenting with exertional angina. AM Heart J 1987, 114:423-427.
18. Sisson JC, Frager MS, Valk TW et al.: Scintigraphic localization of pheochromocytoma. N Engl J Med 1981, 305: 2-17.
19. Jalil ND, Patton FN, Combemale F, et al.: Effectiveness and limits of preoperative imaging studies for the localizations of pheochromocytomas and paragangliomas: a review of 282 cases. Eur J Surg 1998, 164:23-28.
20. van der Harst E, de Herder WW, Bruining HA, et al.: [123I]-metaiodobenzylguanidine and [111In]-octreotide uptake in benign and malignant pheochromocytomas. J Clin Endocrinol Metab 2001, 86:685-693.
21. Ilias I, Yu J, Carrasquillo JA, et al.: Superiority of 6-[18F]-fluorodopamine positron emission tomography versus [131I]-metaiodobenzylguanidine scintigraphy in the localization of metastatic pheochromocytoma. J Clin Endocrinol Metab 2003, 88:4083-4087.
22. Manger WM: Editorial: In search of pheochromocytomas. J Clin Endocrinol Metab 2003, 88:4080-4082.
23. Mantero F, Massimo T, Arnoldi G, et al.: A survey on adrenal incidentaloma in Italy. J Clin Endocrinol Metab 2000, 85:637-644.
24. Manger WM, Gifford RW Jr: Pheochromocytoma: How to diagnose, how to treat. J Clin Hypertension 2002, 4:62-72.
25. Neumann HPH, Reincke M, Bender BU, et al.: Preserved adrenocortical function after laparoscopic bilateral adrenal sparing surgery for hereditary pheochromocytoma. J Clin Endocrinol Metab 1999, 84:2608-2610.
26. Loh K-C, Fitzgerald PA, Matthay KK, et al.: The treatment of malignant pheochromocytoma with iodine-131 metaiodobenzylguanidine (131I-MIBG): a comprehensive review of 116 reported patients. J Endocrinol Invest 1997, 20:648-658.
27. Shapiro B, Sisson JC, Wieland DM, et al.: Radiopharmaceutical therapy of malignant pheochromocytoma with [131I-metaiodobenzylguanidine: results from 10 years experience. J Nucl Biol Med 1991, 35:269-276.
28. Averbush SD, Steakley CS, Young RC, et al.: Malignant pheochromocytoma: effective treatment with a combination of cyclophosphamide, vincristine, and dacarbazine. Ann Intern Med 1988, 109:267-273.
29. Takahashi K, Ashizawa N, Minami T, et al.: Malignant pheochromocytoma with multiple hepatic metastases treated by chemotherapy and transcatheter arterial embolization. Intern Med 1999, 38: 49-354.
30. Pacak K, Fojo T, Golstein DS, et al.: Radiofrequency ablation: a novel approach for treatment of metastatic pheochromocytoma J Natl Cancer Inst 2001, 93:648-649.
31. Sisson JC, Shapiro B, Shulkin BL, et al.: Treatment of malignant pheochromocytomas with 131I-metaiodobenzylguanidine and chemotherapy. Am J Clin Oncol 1999, 22:364-370.